Taking a Bayesian route to the Triple Crown
This article was originally published in The Gray Sheet
"If you have a prior set of events of eight positive outcomes and zero negative outcomes, and you have an increasing effect as demonstrated by a win of 11 and one-half lengths at Pimlico, what is the likelihood of Smarty Jones winning the Triple Crown?" John Sladky, MD, Emory University, asks attendees at an FDA/Johns Hopkins University-sponsored symposium on Bayesian statistical analysis May 21. For coverage of how Bayesian approaches can enhance medical device clinical studies, see story: 1CDRH Promotes Bayesian Tool To Speed Approvals; Statistical Rigor Required...
You may also be interested in...
FDA is encouraging medical device firms to consider using Bayesian estimation in clinical trials to streamline regulatory timeframes
Researchers discussed ways to ensure COVID-19 diagnostics work for all variants during a recent webinar.
Amunix’s XTEN technology for half-life extension and precise drug delivery has been used by multiple partners over the past 15 years, but now the firm is building its own cancer therapy pipeline.